NM_024570.4:c.509dupA
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_024570.4(RNASEH2B):c.509dupA(p.Val171GlyfsTer2) variant causes a frameshift, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000414 in 1,449,854 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. K170K) has been classified as Uncertain significance. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024570.4 frameshift, splice_region
Scores
Clinical Significance
Conservation
Publications
- Aicardi-Goutieres syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
- Aicardi-Goutieres syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024570.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RNASEH2B | NM_024570.4 | MANE Select | c.509dupA | p.Val171GlyfsTer2 | frameshift splice_region | Exon 6 of 11 | NP_078846.2 | ||
| RNASEH2B | NM_001411023.1 | c.509dupA | p.Val171GlyfsTer2 | frameshift splice_region | Exon 6 of 11 | NP_001397952.1 | |||
| RNASEH2B | NM_001142279.2 | c.509dupA | p.Val171GlyfsTer2 | frameshift splice_region | Exon 6 of 10 | NP_001135751.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RNASEH2B | ENST00000336617.8 | TSL:1 MANE Select | c.509dupA | p.Val171GlyfsTer2 | frameshift splice_region | Exon 6 of 11 | ENSP00000337623.2 | ||
| RNASEH2B | ENST00000646960.1 | c.509dupA | p.Val171GlyfsTer2 | frameshift splice_region | Exon 6 of 13 | ENSP00000496481.1 | |||
| RNASEH2B | ENST00000643159.1 | c.419dupA | p.Val141GlyfsTer2 | frameshift splice_region | Exon 8 of 16 | ENSP00000495587.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000414 AC: 6AN: 1449854Hom.: 0 Cov.: 28 AF XY: 0.00000554 AC XY: 4AN XY: 722038 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 2 Pathogenic:2
NM_024570.3(RNASEH2B):c.509dupA(V171Gfs*2) is a frameshift variant classified as pathogenic in the context of Aicardi-Goutieres syndrome. V171Gfs*2 has been observed in a case with relevant disease (PMID: 39630935). Relevant functional assessments of this variant are not available in the literature. V171Gfs*2 has not been observed in referenced population frequency databases. In summary, NM_024570.3(RNASEH2B):c.509dupA(V171Gfs*2) is a frameshift variant in a gene where loss of function is a known mechanism of disease, is predicted to disrupt protein function, and has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening.
This sequence change creates a premature translational stop signal (p.Val171Glyfs*2) in the RNASEH2B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RNASEH2B are known to be pathogenic (PMID: 17846997). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RNASEH2B-related conditions. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at